Cargando…
SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
Autores principales: | Giovannoni, Federico, Quintana, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705403/ https://www.ncbi.nlm.nih.gov/pubmed/33262451 http://dx.doi.org/10.1038/s41422-020-00447-9 |
Ejemplares similares
-
A potential role for AHR in SARS-CoV-2 pathology
por: Giovannoni, Federico, et al.
Publicado: (2020) -
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021) -
Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020) -
Super(antigen) target for SARS-CoV-2
por: Brown, Matthew, et al.
Publicado: (2021) -
A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)